The Jellyvision Lab, Inc.

The Jellyvision Lab, Inc. specializes in providing a hyper-personalized employee benefits management platform that enhances decision-making for employees navigating their benefits options, ultimately leading to increased satisfaction. Founded in 2001 and headquartered in Chicago, US, The Jellyvision Lab, Inc. focuses on employee benefits management through their platform ALEX.

The company raised USD 5. 47 million in Series B funding in March 2017 from Updata Partners, bringing their total amount raised to USD 5. 47 million, with a current valuation of USD 16. 92 million.

Harry Gottlieb, the founder, previously established other ventures before leading Jellyvision, with Amanda Lannert currently serving as CEO. Jellyvision primarily offers a hyper-personalized employee benefits management platform known as ALEX. Released in 2008, ALEX leverages real claims data, behavioral science, and predictive analytics to assist employees in navigating their benefits choices effectively. The platform is designed to foster informed decision-making, ultimately resulting in improved employee satisfaction and engagement with their benefits.

Jellyvision's client base comprises thousands of companies across various industries, including both small businesses and large enterprises, serving millions of employees who rely on these tools during critical times such as open enrollment and life events. The company's products are marketed in North America, with a focus on enhancing the employee experience in the complex landscape of healthcare and benefits. Jellyvision generates revenue primarily through a subscription-based model where employers pay for access to ALEX. These transactions typically occur as annual or multi-year contracts, allowing companies to provide their employees with the ALEX platform as an integral part of their benefits offering.

The firm collaborates with employers, human resources professionals, brokers, and consultants, ensuring that ALEX aligns with the specific needs of organizations in managing their benefits. While specific pricing details are proprietary, Jellyvision's offerings are structured to provide scalable solutions, allowing clients to select options that best fit their organizational needs. This transaction model supports the sustained engagement of employees with their benefits while contributing to Jellyvision's overall financial performance. The Jellyvision Lab, Inc.

intends to leverage the recent Series B funding of USD 5. 47 million to enhance and expand their ALEX platform, with plans for new features and improvements. The company is also looking to expand its market presence beyond North America, targeting new geographic regions in the coming years. Specifically, they are exploring opportunities in the European market by 2025.

The funding will support these initiatives and help in the development of additional products, further aligning with market demands.